Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting

Journal of Clinical Microbiology

Volumn 43, Issue 8, 2005, Pages 4026-4036

  Al Mosaid, Asmaa ^a   Sullivan, Derek J ^a   Polacheck, Itzhack ^b   Shaheen, Faisal A ^c   Soliman, Osama ^d   Al Hedaithy, Saleh ^e   Al Thawad, Sahar ^f   Kabadaya, Motaz ^a   Coleman, David C ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c KING FAHAD GENERAL HOSPITAL   (Saudi Arabia)

^d NATIONAL CANCER INSTITUTE   (Egypt)

^e KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^f KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCYTOSINE; INTERLEUKIN 2 RECEPTOR ALPHA; INTERNAL TRANSCRIBED SPACER; RIBOSOME RNA;

ARTICLE; CANDIDA DUBLINIENSIS; DNA FINGERPRINTING; EGYPT; FUNGUS ISOLATION; GENOTYPE; ISRAEL; MINIMUM INHIBITORY CONCENTRATION; MOUTH; NONHUMAN; PHYLOGENETIC TREE; PRIORITY JOURNAL; RNA GENE; SAUDI ARABIA; SPECIES DIFFERENCE;

ANTIFUNGAL AGENTS; CANDIDA; CYTOSINE DEAMINASE; DNA FINGERPRINTING; DRUG RESISTANCE, FUNGAL; FLUCYTOSINE; MICROBIAL SENSITIVITY TESTS; PENTOSYLTRANSFERASES;

CANDIDA DUBLINIENSIS;

EID: 23744460523     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.8.4026-4036.2005     Document Type: Article

References (52)

1. Ahmad, S., Z. Khan, E. Mokaddas, and Z. U. Khan. 2004. Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait. J. Med. Microbiol. 53:633-637.
2. Al Mosaid, A., D. Sullivan, I. F. Salkin, D. Shanley, and D. C. Coleman. 2001. Differentiation of Candida dubliniensis from Candida albicans on Staib agar and caffeic acid-ferric citrate agar. J. Clin. Microbiol. 39:323-327.
3. Al Mosaid, A., D. J. Sullivan, and D. C. Coleman. 2003. Differentiation of Candida dubliniensis from Candida albicans on Pal's agar. J. Clin. Microbiol. 41:4787-4789,
4. Bagg, J., M. P. Sweeney, M. A. Lewis, M. S. Jackson, D. Coleman, A. Al Mosaid, W. Baxter, S. McEndrick, and S. McHugh. 2003. High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer. Palliat. Med. 17:477-481.
5. Blignaut, E., C. Pujol, S. Joly, and D. R. Soll. 2003. Racial distribution of Candida dubliniensis colonization among South Africans. J. Clin. Microbiol. 41:1838-1842.
6. Blignaut, E., C. Pujol, S. Lockhart, S. Joly, and D. R. Soll. 2002. Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals a new clade in South Africa. J. Clin. Microbiol. 40:826-836.
7. Brandt, M. E., L. H. Harrison, M. Pass, A. N. Sofair, S. Huie, R. K. Li, C. J. Morrison, D. W. Warnock, and R. A. Hajjeh. 2000. Candida dubliniensis fungemia: the first four cases in North America. Emerg. Infect. Dis. 6:46-49.
8. Brena, S., M. del Carmen Rubio, R. Salesa, I. Iglesias, J. Gil, A. Rezusta, M. D. Moragues, and J. Ponton. 2004. Genotypes of Candida dubliniensis in clinical isolates. Rev. Iberoam. Micol. 21:20-23. (In Spanish.)
9. Cardenes-Perera, C. D., A. Torres-Lana, R. Alonso-Vargas, M. D. Moragues-Tosantas, J. Ponton-San Emeterio, G. Quindos-Andres, and M. P. Arevalo-Morales. 2004. Evaluation of API ID 32C and VITEK-2 to identify Candida dubliniensis. Diagn. Microbiol. Infect. Dis. 50:219-221.
10. Carr, M. J., S. Clarke, F. O'Connell, D. J. Sullivan, D. C. Coleman, and B. O'Connell. 2005. First reported case of endocarditis caused by Candida dubliniensis. J. Clin. Microbiol. 43:3023-3026.
11. Coleman, D., D. Sullivan, B. Harrington, K. Haynes, M. Henman, D. Shanley, D. Bennett, G. Moran, C. McCreary, and L. O'Neill. 1997. Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients. Oral Dis. 3(Suppl. 1):S96-S101.
12. Coleman, D. C., D. J. Sullivan, D. E. Bennett, G. P. Moran, H. J. Barry, and D. B. Shanley. 1997. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 11:557-567.
13. Dodgson, A. R., K. J. Dodgson, C. Pujol, M. A. Pfaller, and D. R. Soil. 2004. Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans. Antimicrob. Agents Chemother. 48:2223-2227.
14. Donnelly, S. M., D. J. Sullivan, D. B. Shanley, and D. C. Coleman. 1999. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 145:1871-1882.
15. Fell, J. 1993. Rapid identification of yeast species using three primers in a polymerase chain reaction. Mol. Mar. Biol. Biotechnol. 3:174-180.
16. Fotedar, R., and S. S. Al Hedaithy. 2004. Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients. Mycoses 47:150-155.
17. Fotedar, R., and S. S. A. Al Hedaithy. 2003. Candida dubliniensis at a university hospital in Saudi Arabia. J. Clin. Microbiol. 41:1907-1911.
18. Gee, S. F., S. Joly, D. R. Soll, J. F. G. M. Meis, P. E. Verweij, I. Polacheck, D. J. Sullivan, and D. C. Coleman. 2002. Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo. J. Clin. Microbiol. 40:556-574.
19. Gottlieb, G. S., A. P. Limaye, Y. C. Chen, and W. C. Van Voorhis. 2001. Candida dubliniensis fungemia in a solid organ transplant patient: case report and review of the literature. Med. Mycol. 39:483-485.
20. Hope, W. W., L. Tabernero, D. W. Denning, and M. J. Anderson. 2004. Molecular mechanisms of primary resistance to flucytosine in Candida albicans. Antimicrob. Agents Chemother. 48:4377-4386.
21. Jabra-Rizk, M. A., T. M. Brenner, M. Romagnoli, A. A. M. A. Baqui, W. G. Merz, W. A. Falkler, Jr., and T. F. Meiller. 2001. Evaluation of a reformulated CHROMagar Candida. J. Clin. Microbiol. 39:2015-2016.
22. Joly, S., C. Pujol, M. Rysz, K. Vargas, and D. R. Soll. 1999. Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis. J. Clin. Microbiol. 37:1035-1044.
23. Kirkpatrick, W. R., S. G. Revankar, R. K. McAtee, J. L. Lopez-Ribot, A. W. Fothergill, D. I. McCarthy, S. E. Sanche, R. A. Cantu, M. G. Rinaldi, and T. F. Patterson. 1998. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J. Clin. Microbiol. 36:3007-3012.
24. Lefler, E., M. J. McCullough, K. V. Clemons, and D. A. Stevens. 2001. Initial isolation of Candida dubliniensis from the Middle East. Int. J. Infect. Dis. 5:40-42.
25. Manfredi, M., M. J. McCullough, Z. M. Al-Karaawi, S. J. Hurel, and S. R. Porter. 2002. The isolation, identification and molecular analysis of Candida spp. isolated from the oral cavities of patients with diabetes mellitus. Oral Microbiol. Immunol. 17:181-185.
26. McCullough, M. J., J. J. Jorge, F. Lijbkowicz, E. Lefler, F. Nassar, K. V. Clemons, and D. A. Stevens. 2004. Genotypic differences of Candida albicans and C. dubliniensis isolates related to ethnic/racial differences within the same geographic area. Mycopathologia 158:39-41.
27. McMullan, R., J. Xu, J. E. Moore, B. C. Millar, M. J. Walker, S. T. Irwin, J. Price, J. Barr, and S. Hedderwick. 2002. Candida dubliniensis bloodstream infection in patients with gynaecological malignancy. Eur. J. Clin. Microbiol. Infect. Dis. 21:635-636.
28. Meis, J. F., M. Ruhnke, B. E. De Pauw, F. C. Odds, W. Siegert, and P. E. Verwey. 1999. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg. Infect. Dis. 5:150-153.
29. Moran, G., D. Sullivan, J. Morschhäuser, and D. Coleman. 2002. The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance. Antimicrob. Agents Chemother. 46:2829-2841.
30. Moran, G. P., D. J. Sullivan, M. C. Henman, C. E. McCreary, B. J. Harrington, D. B. Shanley, and D. C. Coleman. 1997. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob. Agents Chemother. 41:617-623.
31. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing for yeasts. Approved standard, 2nd ed. M27-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
32. Pfaller, M. A., S. A. Messer, L. Boyken, H. Huynh, R J. Mollis, and D. J. Diekema. 2002. In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrob. Agents Chemother. 46:3518-3521.
33. Pfaller, M. A., S. A. Messer, S. Gee, S. Joly, C. Pujol, D. J. Sullivan, D. C. Coleman, and D. R. Soll. 1999. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J. Clin. Microbiol. 37:870-872.
34. Pincus, D. H., D. C. Coleman, W. R. Pruitt, A. A. Padhye, I. F. Salkin, M. Geimer, A. Bassel, D. J. Sullivan, M. Clarke, and V. Hearn. 1999. Rapid identification of Candida dubliniensis with commercial yeast identification systems. J. Clin. Microbiol. 37:3533-3539.
35. Pinjon, E., D. Sullivan, I. Salkin, D. Shanley, and D. Coleman. 1998. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J. Clin. Microbiol. 36:2093-2095.
36. Polacheck, I., J. Strahilevitz, D. Sullivan, S. Donnelly, I. F. Salkin, and D. C. Coleman. 2000. Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel. J. Clin. Microbiol. 38:170-174.
37. Ponton, J., R. Ruchel, K. V. Clemons, D. C. Coleman, R. Grillot, J. Guarro, D. Aldebert, P. Ambroise-Thomas, J. Cano, A. J. Carrillo-Munoz, J. Gene, C. Pinel, D. A. Stevens, and D. J. Sullivan. 2002. Emerging pathogens. Med. Mycol. 38:225-236.
38. Pujol, C., M. A. Pfaller, and D. R. Soll. 2004. Flucytosine resistance is restricted to a single genetic clade of Candida albicans. Antimicrob. Agents Chemother. 48:262-266.
39. Quindos, G., M. T. Ruesga, E. Martin-Mazuelos, R. Salesa, R. Alonso-Vargas, A. J. Carrillo-Munoz, S. Brena, R. San Millan, and J. Ponton. 2004. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts. Rev. Iberoam. Micol. 21:63-69. (In Spanish.)
40. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
41. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
42. Sebti, A., T. E. Kiehn, D. Perlin, V. Chaturvedi, M. Wong, A. Doney, S. Park, and K. A. Sepkowitz. 2001. Candida dubliniensis at a cancer center. Clin. Infect. Dis. 32:1034-1038.
43. Soll, D. R. 2000. The ins and outs of DNA fingerprinting the infectious fungi. Clin. Microbiol. Rev. 13:332-370.
44. Staib, P., and J. Morschhäuser. 1999. Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis. Mycoses 42:521-524.
45. Sullivan, D., and D. Coleman. 1998. Candida dubliniensis: characteristics and identification. J. Clin. Microbiol. 36:329-334.
46. Sullivan, D., K. Haynes, J. Bille, P. Boerlin, L. Rodero, S. Lloyd, M. Henman, and D. Coleman. 1997. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J. Clin. Microbiol. 35:960-964.
47. Sullivan, D. J., G. P. Moran, E. Pinjon, A. Al-Mosaid, C. Stokes, C. Vaughan, and D. C. Coleman. 2004. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res. 4:369-376.
48. Sullivan, D. J., T. J. Westerneng, K. A. Haynes, D. E. Bennett, and D. C. Coleman. 1995. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141:1507-1521.
49. Tekeli, A., I. Dolapci, R. Emral, and S. Cesur. 2004. Candida carriage and Candida dubliniensis in oropharyngeal samples of type-1 diabetes mellitus patients. Mycoses 47:315-318.
50. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
51. White, T. J., T. D. Bruns, S. B. Lee, and J. W. Taylor. 1990. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics, p. 315-322. In M. A. Innis, D. H. Gelfand, J. J. Sininsky, and T. J. White (ed.), PCR protocols: a guide to methods and applications. Academic Press, Inc., San Diego, Calif.
52. Willis, A. M., W. A. Coulter, D. J. Sullivan, D. C. Coleman, J. R. Hayes, P. M. Bell, and P. L. Lamey. 2000. Isolation of C. dubliniensis from insulin-using diabetes mellitus patients. J. Oral Pathol. Med. 29:86-90.